← back to search

Patrick Caplazi

AbbVie (United States) · US
Area of research
Immunology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Immune Cell Function and Interaction, Virology and Viral Diseases, and T-cell and B-cell Immunology.
h-index
34
citations
5,869
works
80
NIH funding
primary concept
Medicine
email

Recent publications

LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
Science Advances 2023cited by 48position: middledoi
LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung.
2023cited by 37position: contributordoi
Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone.
2023cited by 19position: contributordoi
Obligate role for Rock1 and Rock2 in adult stem cell viability and function.
2023cited by 5position: contributordoi
A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis
Cell Metabolism 2022cited by 48position: middledoi
Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone
European Respiratory Journal 2022cited by 23position: middledoi
BMP1 is not required for lung fibrosis in mice
Scientific Reports 2022cited by 10position: middledoi
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Science Translational Medicine 2021cited by 130position: middledoi
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis.
2021cited by 108position: contributordoi
Integration of eQTL and a Single-Cell Atlas in the Human Eye Identifies Causal Genes for Age-Related Macular Degeneration
Cell Reports 2020cited by 233position: middledoi
Neutrophil serine protease 4 is required for mast cell-dependent vascular leakage.
2020cited by 12position: contributordoi
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
Cell Death and Differentiation 2019cited by 145position: middledoi
Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation
Cell Reports 2019cited by 72position: middledoi
Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes
Science Immunology 2018cited by 35position: middledoi
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
Thorax 2014cited by 303position: middledoi
Blockade of CSF-1 and IL-34 in mouse model of inflammatory arthritis and colitis show a pathogenic role for IL-34 (P5160)
The Journal of Immunology 2013cited by 1position: middledoi
Replacement of Sϵ with Sμ reveals novel mechanistic insights into rearrangements of the IgH locus and cMyc chromosomal translocations (P1400)
The Journal of Immunology 2013cited by 0position: middledoi
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis
Autoimmunity 2012cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Merone Roose‐Girma · Genmab (United States)5 papers (2012–2023)Zora Modrušan · Genetic Technologies (Australia)5 papers (2014–2023)Jason A. Hackney · Maidstone and Tunbridge Wells NHS Trust3 papers (2020–2023)Lucinda Tam · Gene Therapy Laboratory3 papers (2012–2023)Elsa-Noah N’Diaye · Gilead Sciences (United States)3 papers (2022–2023) · 3 papers (2020–2023)Wendy Sandoval · Genomic Health (United States)3 papers (2022–2023)Ning Ding · Medizinische Hochschule Hannover3 papers (2022–2023)Surinder Jeet · City College of San Francisco3 papers (2013–2023)Wyne P. Lee · ATUM (United States)3 papers (2018–2023)Jason DeVoss · Amgen (United States)3 papers (2012–2018)Hsiao‐Yen Ma · Gene Therapy Laboratory3 papers (2022–2023)Robert Newman · Gene Therapy Laboratory2 papers (2022–2023)David Arnott · Gene Therapy Laboratory2 papers (2018–2019)Hans D. Brightbill · Gene Therapy Laboratory2 papers (2022–2023)Ali A. Zarrin · Gene Therapy Laboratory2 papers (2012–2013) · 2 papers (2012–2018) · 2 papers (2012–2013)Aaron K. Wong · Princeton University2 papers (2022–2023)Kate Senger · Gene Therapy Laboratory2 papers (2012–2013)